Show simple item record

dc.contributor.authorKoppers Lalic, Danijela
dc.contributor.authorHackenberg, Michael
dc.date.accessioned2020-11-05T08:37:02Z
dc.date.available2020-11-05T08:37:02Z
dc.date.issued2016-04-19
dc.identifier.citationKoppers-Lalic, D., Hackenberg, M., De Menezes, R., Misovic, B., Wachalska, M., Geldof, A., ... & Van Moorselaar, J. (2016). Non-invasive prostate cancer detection by measuring miRNA variants (isomiRs) in urine extracellular vesicles. Oncotarget, 7(16), 22566. [DOI: 10.18632/oncotarget.8124]es_ES
dc.identifier.urihttp://hdl.handle.net/10481/64066
dc.descriptionThe authors thank J. Bossenga for collecting urine and P.P. Eijk for their technical assistance in smallRNA sequencing library preparations.es_ES
dc.description.abstractIn many cancer types, the expression and function of ~22 nucleotide‑long microRNAs (miRNA) is deregulated. Mature miRNAs can be stably detected in extracellular vesicles (EVs) in biofluids, therefore they are considered to have great potential as biomarkers. In the present study, we investigated whether miRNAs have a distinct expression pattern in urine‑EVs of prostate cancer (PCa) patients compared to control males. By next generation sequencing, we determined the miRNA expression in a discovery cohort of 4 control men and 9 PCa patients. miRNAs were validated by using a stemloop RT‑PCR in an independent cohort of 74 patients (26 control and 48 PCa‑patients). Whereas standard mapping protocols identified > 10 PCa associated miRNAs in urinary EVs, miR‑21, miR‑375 and miR‑204 failed to robustly discriminate for disease in a validation study with RT‑PCR‑detection of mature miRNA sequences. In contrast, we observed that miRNA isoforms (isomiRs) with 3′ end modifications were highly discriminatory between samples from control men and PCa patients. Highly differentially expressed isomiRs of miR‑21, miR‑204 and miR‑375 were subsequently validated in an independent group of 74 patients. Receiver‑operating characteristic analysis was performed to evaluate the diagnostic performance of three isomiRs, resulting in a 72.9% sensitivity with a high (88%) specificity and an area under the curve (AUC) of 0.866. In comparison, prostate specific antigen had an AUC of 0.707 and measuring the mature form of these miRNAs yielded a lower 70.8% sensitivity and 72% specificity (AUC 0.766). We propose that isomiRs may carry discriminatory information which is useful to generate stronger biomarkers.es_ES
dc.description.sponsorshipStichting Urologie 1973es_ES
dc.description.sponsorshipVUmc-CCAes_ES
dc.description.sponsorshipWorldwide Cancer Research (AICR) 15-1005es_ES
dc.description.sponsorshipKWF-VU-5510es_ES
dc.description.sponsorshipWorldwide Cancer Research 15-1005es_ES
dc.language.isoenges_ES
dc.publisherImpact Journals LLCes_ES
dc.rightsAtribución 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectLiquid biopsyes_ES
dc.subjectIsomiRses_ES
dc.subjectMiRNAes_ES
dc.subjectRNA sequencinges_ES
dc.subjectExtracellular vesicleses_ES
dc.titleNon‑invasive prostate cancer detection by measuring miRNA variants (isomiRs) in urine extracellular vesicleses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.doi10.18632/oncotarget.8124
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES


Files in this item

[PDF]

This item appears in the following Collection(s)

Show simple item record

Atribución 3.0 España
Except where otherwise noted, this item's license is described as Atribución 3.0 España